focus -WSS

focus

author：fashion 2025-09-29 21:28:27 - browse：771

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： How dance can help nurses traumatized by Covid

Wikipedia

WSS

Russian special forces kill a gunman who broke into a private house near Moscow

Biden tests positive for Covid

HIPAA doesn't protect reproductive records from prosecutors

Caitlin Bernard's story shows physicians can't shy from advocacy

White House launches permanent pandemic office

Medicare has a new plan to address drug shortages

knowledge

focus

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How artificial intelligence is being used to detect, treat cancer

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

As digital health tech proliferates, a new institute aims to cut through hype

In Memoriam: Notable people who died in 2023

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

The high cost of giving birth even with insurance

AbbVie dramatically boosts its spending on lobbying

23andMe had bad news about my health. I wish a person had delivered it

Body of missing toddler recovered in Delaware River days after flood: Police

hotspot

Custom gene therapy hints at new path for rare disease treatments

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

HIPAA doesn't protect reproductive records from prosecutors

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Organ transplantation is at a crossroads. Major reform is needed

New rules on organ donation and transplantation 'will bring chaos'

focus

Wikipedia

knowledge

hotspot